AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Erratum for Garvey et al., Antimicrob. Agents Chemother. 52 (3) 901-908.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Garvey, E. P.
Right arrow Articles by Fujiwara, T.
PubMed
Right arrow Articles by Garvey, E. P.
Right arrow Articles by Fujiwara, T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2008, p. 1899, Vol. 52, No. 5
0066-4804/08/$08.00+0     doi:10.1128/AAC.00270-08

ERRATUM

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

Edward P. Garvey, Brian A. Johns, Margaret J. Gartland, Scott A. Foster, Wayne H. Miller, Robert G. Ferris, Richard J. Hazen, Mark R. Underwood, Eric E. Boros, James B. Thompson, Jason G. Weatherhead, Cecilia S. Koble, Scott H. Allen, Lee T. Schaller, Ronald G. Sherrill, Tomokazu Yoshinaga, Masanori Kobayashi, Chiaki Wakasa-Morimoto, Shigeru Miki, Koichiro Nakahara, Takeshi Noshi, Akihiko Sato, and Tamio Fujiwara

Departments of Virology and Medicinal Chemistry, Infectious Diseases Center of Excellence for Drug Discovery, and Department of Discovery Technology Group, Molecular Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina 27709, and Shionogi Research Laboratories, Shionogi and Company, Ltd., Mishima, Settsu-shi, Osaka 556-0022, Japan

Volume 52, no. 3, p. 901-908, 2008. Page 906, Table 2: The second culture day should be "28" instead of "18." For culture days 28 and 42, "T661-T124A" should read "T66I-T124A." For culture day 56, "Q146S-T124A" should read "Q146L-T124A."

Antimicrobial Agents and Chemotherapy, May 2008, p. 1899, Vol. 52, No. 5
0066-4804/08/$08.00+0     doi:10.1128/AAC.00270-08





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Garvey, E. P.
Right arrow Articles by Fujiwara, T.
PubMed
Right arrow Articles by Garvey, E. P.
Right arrow Articles by Fujiwara, T.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS